Table 1.
Demographic and clinical data (n=40)
| Age (years ± SD) | 80.1±7.6 |
| Women (%) | 42.5 |
| BMI (kg/m2) | 26.8±3.6 |
| Cardiovascular risk factors | |
| Hypertension (%) | 61.5 |
| Dyslipidemia (%) | 59.0 |
| Diabetes mellitus (%) | 27.5 |
| Current smoker (%) | 5.1 |
| Family history of CAD (%) | 30.8 |
| Medication | |
| Β-blockers (%) | 20.0 |
| ACE/ARB (%) | 27.5 |
| Calcium antagonists (%) | 22.5 |
| Nitrates (%) | 7.5 |
| Diuretics (%) | 55.0 |
| Comorbidities | |
| Coronary artery disease (%) | 35.0 |
| Previous stroke (%) | 30.8 |
| COPD (%) | 26.6 |
| Renal disease (%) | 30.8 |
| Symptoms | |
| NYHA Class 3 or 4 (%) | 50.0 |
| Angina CCS classification 3 or 4 (%) | 0.0 |
| Vertigo (%) | 36.8 |
Abbreviations: BMI, body mass index; ACE, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor blockers; NYHA, New York Heart Association; CCS, Canadian Cardiovascular Society; CAD, coronary artery disease; COPD, Chronic Obstructive Pulmonary Disease.